BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12043408)

  • 1. [Bacteremia and meningitis caused by Streptococcus pneumoniae during treatment with azithromycin].
    Lisby JG; Brasholt M; Teglbjoerg LL
    Ugeskr Laeger; 2002 May; 164(20):2629. PubMed ID: 12043408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteremia and meningitis caused by a macrolide-sensitive strain of Streptococcus pneumoniae during treatment with azithromycin.
    Lisby G; Brasholt MS; Teglbjerg MS
    Clin Infect Dis; 2001 Aug; 33(3):415-6. PubMed ID: 11438918
    [No Abstract]   [Full Text] [Related]  

  • 3. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin.
    Kelley MA; Weber DJ; Gilligan P; Cohen MS
    Clin Infect Dis; 2000 Oct; 31(4):1008-11. PubMed ID: 11049784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study.
    Schentag JJ; Klugman KP; Yu VL; Adelman MH; Wilton GJ; Chiou CC; Patel M; Lavin B; Paladino JA
    Int J Antimicrob Agents; 2007 Sep; 30(3):264-9. PubMed ID: 17587549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of macrolide resistance in Streptococcus pneumoniae.
    Nuermberger EL; Bishai WR
    J Antimicrob Chemother; 2003 Sep; 52(3):524-5; author reply 525. PubMed ID: 12888594
    [No Abstract]   [Full Text] [Related]  

  • 6. Macrolide and ketolide resistance with Streptococcus pneumoniae.
    Doern GV
    Med Clin North Am; 2006 Nov; 90(6):1109-24. PubMed ID: 17116439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae.
    Bergman M; Huikko S; Huovinen P; Paakkari P; Seppälä H;
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3646-50. PubMed ID: 16940064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakthrough sepsis in macrolide-resistant pneumococcal infection.
    Jackson MA; Burry VF; Olson LC; Duthie SE; Kearns GL
    Pediatr Infect Dis J; 1996 Nov; 15(11):1049-51. PubMed ID: 8933560
    [No Abstract]   [Full Text] [Related]  

  • 9. Serious bacterial infection in children.
    Bergus G
    J Fam Pract; 1997 Jun; 44(6):531-2. PubMed ID: 9191620
    [No Abstract]   [Full Text] [Related]  

  • 10. Austrian syndrome caused by highly penicillin-resistant Streptococcus pneumoniae.
    Muñoz P; Sainz J; Rodríguez-Creixéms M; Santos J; Alcalá L; Bouza E
    Clin Infect Dis; 1999 Dec; 29(6):1591-2. PubMed ID: 10585831
    [No Abstract]   [Full Text] [Related]  

  • 11. Inferring the potential success of pneumococcal vaccination in Italy: serotypes and antibiotic resistance of Streptococcus pneumoniae isolates from invasive diseases.
    Pantosti A; Boccia D; D'Ambrosio F; Recchia S; Orefici G; Moro ML; ;
    Microb Drug Resist; 2003; 9 Suppl 1():S61-8. PubMed ID: 14633369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
    Jacobs MR
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new twist on an old problem. A case of pediatric meningitis caused by multidrug-resistant Streptococcus pneumoniae serotype 19 A.
    Ciccotelli WA; Poutanen SM; Alqahtani M; Morris SK; Cox P; Low DE; Pillai DR; Opavsky MA
    Pediatr Infect Dis J; 2009 Jan; 28(1):74-5. PubMed ID: 19057453
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
    Zhanel GG; DeCorby M; Noreddin A; Mendoza C; Cumming A; Nichol K; Wierzbowski A; Hoban DJ
    J Antimicrob Chemother; 2003 Jul; 52(1):83-8. PubMed ID: 12775677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakthrough pneumococcal meningitis in a patient treated with pristinamycin.
    Goldstein F; Jonte J; Mandel F; Ben Ali A
    Clin Microbiol Infect; 2006 Jul; 12(7):696-7. PubMed ID: 16774574
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Ross JJ; Worthington MG; Gorbach SL
    N Engl J Med; 2002 Jul; 347(1):65-7; author reply 65-7. PubMed ID: 12097545
    [No Abstract]   [Full Text] [Related]  

  • 17. Change in pneumococcal susceptibility to azithromycin during treatment for acute otitis media.
    Toltzis P; Dul M; Blumer J
    Pediatr Infect Dis J; 2007 Jul; 26(7):647-9. PubMed ID: 17596812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
    Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae.
    Lonks JR; Garau J; Gomez L; Xercavins M; Ochoa de Echagüen A; Gareen IF; Reiss PT; Medeiros AA
    Clin Infect Dis; 2002 Sep; 35(5):556-64. PubMed ID: 12173129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution.
    Saha SK; Naheed A; El Arifeen S; Islam M; Al-Emran H; Amin R; Fatima K; Brooks WA; Breiman RF; Sack DA; Luby SP;
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S75-81. PubMed ID: 19191622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.